nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—Lansoprazole—MAPT—Parkinson's disease	0.205	0.828	CrCbGaD
Thiabendazole—Lansoprazole—CYP2D6—Parkinson's disease	0.0248	0.1	CrCbGaD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.0212	0.0282	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.0194	0.0258	CbGpPWpGaD
Thiabendazole—CYP1A2—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.0182	0.0241	CbGpPWpGaD
Thiabendazole—CYP1A1—Xenobiotics—CYP2D6—Parkinson's disease	0.0178	0.0236	CbGpPWpGaD
Thiabendazole—Lansoprazole—ABCB1—Parkinson's disease	0.0177	0.0717	CrCbGaD
Thiabendazole—CYP1A1—Estrogen metabolism—NQO1—Parkinson's disease	0.0175	0.0232	CbGpPWpGaD
Thiabendazole—CYP1A1—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.0171	0.0227	CbGpPWpGaD
Thiabendazole—CYP1A1—Xenobiotics—CYP2E1—Parkinson's disease	0.0162	0.0216	CbGpPWpGaD
Thiabendazole—CYP1A1—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.0156	0.0207	CbGpPWpGaD
Thiabendazole—CYP1A2—Methylation—COMT—Parkinson's disease	0.0149	0.0198	CbGpPWpGaD
Thiabendazole—CYP1A1—Estrogen metabolism—COMT—Parkinson's disease	0.0146	0.0194	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—DDC—Parkinson's disease	0.0146	0.0194	CbGpPWpGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.0135	0.018	CbGpPWpGaD
Thiabendazole—CYP1A1—Estrogen metabolism—GSTM1—Parkinson's disease	0.0134	0.0178	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.0132	0.0175	CbGpPWpGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.0124	0.0164	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—MAOB—Parkinson's disease	0.0123	0.0163	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—NQO1—Parkinson's disease	0.0116	0.0154	CbGpPWpGaD
Thiabendazole—CYP1A2—Xenobiotics—CYP2D6—Parkinson's disease	0.0113	0.015	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen metabolism—NQO1—Parkinson's disease	0.0111	0.0148	CbGpPWpGaD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.0109	0.0145	CbGpPWpGaD
Thiabendazole—CYP1A2—Xenobiotics—CYP2E1—Parkinson's disease	0.0104	0.0138	CbGpPWpGaD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00996	0.0132	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00992	0.0132	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—SOD1—Parkinson's disease	0.00992	0.0132	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—MAOA—Parkinson's disease	0.00966	0.0128	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—HMOX1—Parkinson's disease	0.00955	0.0127	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen metabolism—COMT—Parkinson's disease	0.00933	0.0124	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—DDC—Parkinson's disease	0.00929	0.0123	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00925	0.0123	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—SOD2—Parkinson's disease	0.00893	0.0119	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen metabolism—GSTM1—Parkinson's disease	0.00854	0.0113	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—GPX1—Parkinson's disease	0.00852	0.0113	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.00841	0.0112	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00834	0.0111	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.00825	0.011	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00825	0.011	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00804	0.0107	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—MAOB—Parkinson's disease	0.00782	0.0104	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00752	0.00999	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00737	0.00979	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00727	0.00966	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00677	0.009	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00674	0.00896	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00665	0.00884	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00633	0.00841	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00598	0.00794	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.0059	0.00783	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00566	0.00752	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00547	0.00726	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00532	0.00706	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00529	0.00702	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.00526	0.00698	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00526	0.00698	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTA4—Parkinson's disease	0.00522	0.00694	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00513	0.00681	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—APOE—Parkinson's disease	0.0048	0.00637	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTA4—Parkinson's disease	0.00479	0.00637	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00473	0.00628	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.0047	0.00624	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00464	0.00616	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.0045	0.00597	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—CTGF—Parkinson's disease	0.00446	0.00592	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—Parkinson's disease	0.00436	0.00579	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.0043	0.00571	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—MAOB—Parkinson's disease	0.00427	0.00567	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00424	0.00564	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00381	0.00506	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00361	0.0048	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00348	0.00463	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.00331	0.0044	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2D6—Parkinson's disease	0.00317	0.00422	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00313	0.00416	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.00306	0.00406	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00301	0.004	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—Parkinson's disease	0.003	0.00399	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2E1—Parkinson's disease	0.0029	0.00386	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00287	0.00381	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00286	0.0038	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.00272	0.00362	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00265	0.00353	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.00262	0.00348	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.00261	0.00347	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—COMT—Parkinson's disease	0.00241	0.0032	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.00241	0.0032	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.00241	0.0032	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.0024	0.00319	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTP1—Parkinson's disease	0.00239	0.00318	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—MAOA—Parkinson's disease	0.00239	0.00317	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—COMT—Parkinson's disease	0.00237	0.00315	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00236	0.00314	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTM1—Parkinson's disease	0.0022	0.00292	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00217	0.00288	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.00211	0.00281	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.00202	0.00269	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.002	0.00265	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.00185	0.00246	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00183	0.00243	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00169	0.00225	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00166	0.0022	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ND3—Parkinson's disease	0.00156	0.00207	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MCCC1—Parkinson's disease	0.00156	0.00207	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.00153	0.00204	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.00153	0.00204	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.00153	0.00204	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.00153	0.00203	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.00152	0.00202	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.00151	0.00201	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00151	0.002	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TALDO1—Parkinson's disease	0.00147	0.00195	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—OMD—Parkinson's disease	0.00147	0.00195	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.0014	0.00186	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NDUFB11—Parkinson's disease	0.00139	0.00185	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00138	0.00184	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GCH1—Parkinson's disease	0.00133	0.00176	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.0012	0.00159	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GBA—Parkinson's disease	0.00118	0.00157	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—FBP1—Parkinson's disease	0.00118	0.00157	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—DBH—Parkinson's disease	0.00118	0.00157	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00106	0.0014	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MCCC1—Parkinson's disease	0.000995	0.00132	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ND3—Parkinson's disease	0.000995	0.00132	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TALDO1—Parkinson's disease	0.000935	0.00124	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—OMD—Parkinson's disease	0.000935	0.00124	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	0.000887	0.00118	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—DDC—Parkinson's disease	0.000868	0.00115	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GCH1—Parkinson's disease	0.000846	0.00112	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA4—Parkinson's disease	0.000819	0.00109	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000809	0.00107	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000763	0.00101	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GBA—Parkinson's disease	0.000754	0.001	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—DBH—Parkinson's disease	0.000754	0.001	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—FBP1—Parkinson's disease	0.000754	0.001	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	0.000738	0.00098	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MAOB—Parkinson's disease	0.00073	0.00097	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000695	0.000923	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—DDC—Parkinson's disease	0.000553	0.000735	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	0.000543	0.000721	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CTGF—Parkinson's disease	0.000533	0.000708	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA4—Parkinson's disease	0.000523	0.000694	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000516	0.000685	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	0.000496	0.00066	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NQO1—Parkinson's disease	0.000491	0.000652	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TH—Parkinson's disease	0.000484	0.000643	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	0.00047	0.000625	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MAOB—Parkinson's disease	0.000466	0.000619	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYCS—Parkinson's disease	0.000465	0.000617	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000443	0.000589	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—COMT—Parkinson's disease	0.000411	0.000547	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTP1—Parkinson's disease	0.000409	0.000544	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MAOA—Parkinson's disease	0.000408	0.000543	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMOX1—Parkinson's disease	0.000404	0.000536	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCB1—Parkinson's disease	0.000388	0.000515	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTM1—Parkinson's disease	0.000376	0.0005	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GPX1—Parkinson's disease	0.00036	0.000479	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	0.000346	0.00046	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CTGF—Parkinson's disease	0.00034	0.000451	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTHFR—Parkinson's disease	0.000333	0.000442	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	0.000317	0.000421	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NQO1—Parkinson's disease	0.000313	0.000416	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOE—Parkinson's disease	0.00031	0.000411	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TH—Parkinson's disease	0.000309	0.00041	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYCS—Parkinson's disease	0.000296	0.000393	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—INS—Parkinson's disease	0.000264	0.000351	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—COMT—Parkinson's disease	0.000262	0.000348	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTP1—Parkinson's disease	0.000261	0.000347	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MAOA—Parkinson's disease	0.00026	0.000346	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMOX1—Parkinson's disease	0.000257	0.000342	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCB1—Parkinson's disease	0.000247	0.000328	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTM1—Parkinson's disease	0.00024	0.000319	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GPX1—Parkinson's disease	0.00023	0.000305	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTHFR—Parkinson's disease	0.000212	0.000282	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOE—Parkinson's disease	0.000197	0.000262	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—INS—Parkinson's disease	0.000169	0.000224	CbGpPWpGaD
